Peptide dendrimers

Journal of Peptide Science

Volumn 11, Issue 12, 2005, Pages 757-788

  Niederhafner, Petr ^a   Šebestík, Jaroslav ^a   Ježek, Jan ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Multiple antigen peptides (MAPs); Multiple antigenic peptides; Peptide dendrimers; Synthetic vaccine

Indexed keywords

ALLERGEN; ANTIGEN; BACTERIAL VACCINE; CANCER ANTIBODY; CATION; CIPROFLOXACIN; DENDRIMER; DRUG CARRIER; DRUG VEHICLE; EPSTEIN BARR VIRUS VACCINE; FUNGUS VACCINE; HEPATITIS VACCINE; INFLUENZA VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS VACCINE;

ALZHEIMER DISEASE; APOPTOSIS; AUTOIMMUNE DISEASE; BIOLOGICAL ACTIVITY; CATALYSIS; CHEMICAL ANALYSIS; COMPLEX FORMATION; DRUG STRUCTURE; DRUG TRANSPORT; ENCEPHALITIS; EPSTEIN BARR VIRUS; EQUINE INFECTIOUS ANEMIA VIRUS; HERPES SIMPLEX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS BURSAL DISEASE VIRUS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEASLES VIRUS; MYCOBACTERIUM TUBERCULOSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PURIFICATION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; STREPTOCOCCUS MUTANS; STRUCTURE ACTIVITY RELATION; SYNTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE FUNCTION;

DENDRIMERS; PEPTIDES; TERMINOLOGY; VACCINES, SYNTHETIC;

BACTERIA (MICROORGANISMS); EQUINE INFECTIOUS ANEMIA VIRUS; FUNGI; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS BURSAL DISEASE VIRUS; MEASLES VIRUS; MYCOBACTERIUM TUBERCULOSIS; SIMIAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS; STREPTOCOCCUS MUTANS;

EID: 29444443519     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.721     Document Type: Review

References (173)

1. Dykes GM. Dendrimers: a review of their appeal and applications. J. Chem. Technol. Biotechnol. 2001; 76: 903-918 [A Review].
2. Boas U, Heegaard PHM. Dendrimers in drug research. Chem. Soc. Rev. 2004; 33: 43-63 [A Review].
3. Chung YM, Rhee HK. Internal/external use of dendrimer in catalysis. Korean J. Chem. Eng. 2004: 21: 81-97 [A Review].
4. Liu MJ, Frechet JMJ. Designing dendrimers for drug delivery. Pharm. Sci. Technol. Today 1999: 2: 393-401 [A Review].
5. Buhleier E, Wehner W, Vogtle F. Cascade- and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis 1978; 155-158.
6. Denkewalter RG, Kolc JF, Lukasavage WJ. 1983; Patent US4410688.
7. Tomalia DA, Dewald JR. 1983; Patent US4507466.
8. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P. A new class of polymers-starburst-dendritic macromolecules. Polym. J. 1985; 17: 117-132.
9. Vepřek P, Ježek J. Peptide and glycopeptide dendrimers, Part I. J. Pept. Sci. 1999; 5: 5-23 [A Review].
10. Vepřek P, Ježek J. Peptide and glycopeptide dendrimers, Part II. J. Pept. Sci. 1999: 5: 203-220 [A Review].
11. Sadler K, Tam JP. Peptide dendrimers: applications and synthesis. Rev. Mol. Biotechnol. 2002; 90: 195-229 [A Review].
12. Tam JP. Macropeptide structures. Synthesis of peptide dendrimers and protein mimetics. In Houben-Weyl, Methods of Organic Chemistry, Synthesis of Peptides and Peptidomimetics, Vol. E 22d, Goodman M, Felix A, Moroder L, Toniolo C (eds). Georg Thieme Verlag: Stuttgart, 2004; 129-168.
13. Ong W, Goméz-Kaifer M, Kaifer EA. Dendrimers as guests in molecular recognition phenomena. Chem. Commun. 2004; 1677-1683 [A Review].
14. Arima H. Polyfection as nonviral gene transfer method-design of novel nonviral vector using alpha-cyclodextrin. Yakugaku Zasshi-J. Pharm. Soc. Jpn. 2004; 124: 451-464 [A Review].
15. Esfand R, Tomalia DA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today 2001; 6: 427-436 [A Review].
16. Tomalia DA. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichimica Acta 2004; 37: 39-57 [A Review].
17. Roovers J, Comanita B. Dendrimers and dendrimer-polymer hybrids. Adv. Polym. Sci. 1999; 142: 179-228 [A Review].
18. Vogtle F, Gestermann S, Hesse R, Schwierz H, Windisch B. Functional dendrimers. Prog. Polym. Sci. 2000; 25: 987-1041 [A Review].
19. Inoue K. Functional dendrimers, hyperbranched and star polymers. Prog. Polym. Sci. 2000; 25: 453-571 [A Review].
20. Nummelin S, Skrifvars M, Rissanen K. Polyester and ester functionalized dendrimers. Top. Curr. Chem. 2000; 210: 1-67 [A Review].
21. Istratov V, Kautz H, Kim YK, Schubert R, Frey H. Linear-dendritic nonionic poly(propylene oxide)-polyglycerol surfactants. Tetrahedron 2003; 59: 4017-4024.
22. Maes W, Amabilino DB, Dehaen W. Synthesis of novel dendrimers containing pyrimidine units. Tetrahedron 2003; 59: 3937-3943.
23. Venturi M, Ceroni P. Dendrimers with electroactive units in the core or each branching centre. Compt. Rend. Chim. 2003; 6: 935-945 [A Review].
24. Venturi M, Balzani V, Ballardini R, Credi A, Gandolfi MT. Towards molecular photochemionics. Int. J. Photoenergy 2004; 6: 1-10 [A Review].
25. Newkome GR, Yoo KS, Hwang SH, Moorefield CN. Metallodendrimers: homo-and heterogeneous tier construction by bis(2,2′:6′,2″-terpyridinyl)Ru(II) complex connectivity. Tetrahedron 2003; 59: 3955-3964.
26. Stoddart FJ, Welton T. Metall-containing dendritic polymers. Polyhedron 1999; 18: 3575-3591 [A Review].
27. Twyman LJ, King ASH, Martin IK. Catalysis inside dendrimers. Chem. Soc. Rev. 2002; 31: 69-82 [A Review].
28. Astruc D, Blais JC, Cloutet E, Djakovitch L, Rigaut S, Ruiz J, Sartor V, Valerio C. The first organometallic dendrimers: design and redox functions. Top. Curr. Chem. 2000; 210: 229-259 [A Review].
29. Cuadrado I, Moran M, Casado CM, Alonso B, Losada J. Organometallic dendrimers with transition metals. Coord. Chem. Rev. 1999; 195: 395-445 [A Review].
30. Frey H, Lach C, Lorenz K. Heteroatom-based dendrimers. Adv. Mater. 1998; 10: 279-293 [A Review].
31. Peris E. From long-chain conjugated oligomers to dendrimers: synthesis and physical properties of phenyl-ethenyl-ferrocenyl containing one-and two-dimensional complexes. Coord. Chem. Rev. 2004; 248: 279-297 [A Review].
32. Roy R, Kim JM. Cu(II)-self-assembling bipyridyl-glycoclusters and dendrimers bearing the Tn-antigen cancer marker: syntheses and lectin binding properties. Tetrahedron 2003; 59: 3881-3893.
33. Boysen MMK, Lindhorst TK. "Sugaring" carbosilane dendrimers via hydrosilylation. Tetrahedron 2003; 59: 3895-3898.
34. Romagnoli B, Hayes W. Chiral dendrimers-from architecturally interesting hyperbranched macromolecules to functional materials. J. Mater. Chem. 2002; 12: 767-799 [A Review].
35. Lukevics E, Arsenyan P, Pudova O. Silicon-based dendrimers. Main Group Met. Chem. 2002; 25: 135-154 [A Review].
36. Lang H, Luhmann B. Siloxane and carbosiloxane based dendrimers: synthesis, reaction chemistry, and potential applications. Adv. Mater. 2001; 13: 1523-1540 [A Review].
37. Sekiguchi A, Lee VY, Nanjo M. Lithiosilanes and their applications to the synthesis of polysilane dendrimers. Coord. Chem. Rev. 2000; 210: 11-45 [A Review].
38. Frey H, Schlenk C. Silicon-based dendrimers. Top. Curr. Chem. 2000; 210: 69-129 [A Review].
39. Schlenk C, Frey H. Carbosilane dendrimers-synthesis, functionalization, application. Monatsh. Chem. 1999; 130: 3-14 [A Review].
40. Zimmerman SC, Lawless LJ. Supramolecular chemistry of dendrimers. Top. Curr. Chem. 2001; 217: 95-120 [A Review].
41. Demus D. One century liquid crystal chemistry: from Vorlander's rods to discs, stars and dendrites. Mol. Cryst. Liq. Cryst. 2001; 364: 25-91 [A Review].
42. Rossell O, Seco M, Angurell I. Synthesis of transition metal-containing carbosilane dendrimers. Compt. Rend. Chim. 2003: 6: 803-817 [A Review].
43. Jonsson C, Hallman K, Andersson H, Stemme G, Malkoch M, Malstrom E, Hult A, Momberg C. Immobilized oxazoline-containing ligands in asymmetric catalysis-a review. Bioorg. Med. Chem. Lett. 2002; 12: 1857-1861 [A Review].
44. Reek JNH, de Groot D, Oosterom GE, Kamer PCJ, van Leeuwen PWNM. Phosphine-functionalized dendrimers for transition-metal catalysis. Compt. Rend. Chim. 2003; 6: 1061-1077 [A Review].
45. Caminade AM, Maraval V, Laurent R, Majoral JP. Organometallic derivatives of phosphorus-containing dendrimers. Synthesis, properties and applications in catalysis. Curr. Org. Chem. 2002; 6: 739-774 [A Review].
46. Majoral JP, Caminade AM, Laurent R, Sutra P. Phosphorus-containing dendrimers: from material science to biology. Heteroat. Chem. 2002; 13: 474-485 [A Review].
47. Turrin CO, Maraval V, Leclaire J, Dantras E, Lacabanne C, Caminade AM, Majoral JP. Surface, core and structure modifications of phosphorus-containing dendrimers. Influence on the thermal stability. Tetrahedron 2003; 59: 3965-3973.
48. Inoue K, Itaya T. Synthesis and functionality of cyclophosphazene-based polymers. Bull. Chem. Soc. Jpn. 2001; 74: 1381-1395 [A Review].
49. Brocorens P, Zojer E, Cornil J, Shuai Z, Leising G, Mullen K, Bredas JL. Theoretical characterization of phenylene-based oligomers, polymers, and dendrimers. Synth. Met. 1999; 100: 141-162 [A Review].
50. Scherf U. Oligo-and polyarylenes, oligo-and polyarylenevinylenes. Top. Curr. Chem. 1999; 201: 163-222 [A Review].
51. Herrmann A, Mihov G, Vandermeulen GWM, Klok HA, Mullen K. Peptide-functionalized polyphenylene dendrimers. Tetrahedron 2003; 59: 3925-3935.
52. Romagnoli B, Ashton PR, Harwood LM, Philp D, Price DW, Smith MH, Hayes W. Synthesis and properties of polyaromatic dendrimers possessing a repetitive amide-ester coupling sequence. Tetrahedron 2003; 59: 3975-3988.
53. Tam JP. Synthetic peptide vaccine design-synthesis and properties of high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 5409-5413.
54. Crespo L, Sanclimens G, Pons M, Giralt E, Royo M, Albericio F. Peptide and amide bond-containing dendrimers. Chem. Rev. 2005; 105: 1663-1681 [A Review].
55. Bezouška K. Design, functional evaluation and biomedical applications of carbohydrate dendrimers (glycodendrimers). Rev. Mol. Biotechnol. 2002; 90: 269-290 [A Review].
56. Turnbull WB, Stoddard JF. Design and synthesis of glycodendrimers. Rev. Mol. Biotechnol. 2002; 90: 231-255 [A Review].
57. Newkome GR, Moorefield CN, Vogtle F. Dendrimers and Dendrons: Concepts, Syntheses and Applications. Wiley-VCH: Weinheim, 2001.
58. Juris A, Venturi M, Ceroni P, Balzani V, Campagna S, Serroni S. Dendrimers based on electroactive metal complexes. A review of recent advances. Collect. Czech. Chem. Commun. 2001; 66: 1-32 [A Review].
59. Cardona CM, Mendoza S, Kaifer AE. Electrochemistry of encapsulated redox centers. Chem. Soc. Rev. 2000; 29: 37-42 [A Review].
60. Pyell U. Determination and regulation of the migration window in electrokinetic chromatography. J. Chromatogr., A 2004; 1037: 479-490 [A Review].
61. Peric I, Kenndler E. Recent developments in capillary electrokinetic chromatography with replaceable charged pseudostationary phases or additives. Electrophoresis 2003; 24: 2924-2934 [A Review].
62. Castagnola M, Zuppi C, Rossetti DV, Vincenzoni F, Lupi A, Vitali A, Meucci E, Messana I. Characterization of dendrimer properties by capillary electrophoresis and their use as pseudostationary phases. Electrophoresis 2002; 23: 1769-1778 [A Review].
63. Haynes JL, Warner IM. Polymeric surfactants as pseudostationary phases for separations in electrokinetic chromatography (EKC): a review. Crit. Rev. Anal. Chem. 1999; 18: 317-382 [A Review].
64. Aulenta F, Hayes W, Rannard S. Dendrimers: a new class of nanoscopic containers and delivery devices. Eur. Polym. J. 2003; 39: 1741-1771 [A Review].
65. Florence AT, Hussain N. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv. Drug Delivery Rev. 2001; 50: 69-89. Supplement 1 [A Review].
66. Froehling PE. Dendrimers and dyes-a review. Dyes and Pigments 2001; 48: 187-195 [A Review].
67. Dahan A, Portnoy M. Dendrons and dendritic catalysts immobilized on solid support: synthesis and dendritic effects in catalysis. J. Folym. Sci. Part A: Polym. Chem. 2005; 43: 235-262 [A Review].
68. Baars MWPL, Meijer EW. Host-guest chemistry of dendritic molecules. Top. Curr. Chem. 2000; 210: 131-182 [A Review].
69. Paddle BM. Therapy and prophylaxis of inhaled biological toxins. J. Appl. Toxicol. 2003; 23: 139-170 [A Review].
70. Dass CR. Vehicles for oligonucleotide delivery to tumors. J. Pharm. Pharmacol. 2002; 54: 3-27 [A Review].
71. Dass CR, Su T. Particle-mediated intravascular delivery of oligonucleotides to tumors: associated biology and lessons from genotherapy. Drug Delivery 2001; 8: 191-213 [A Review].
72. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mule J, Baker JR Jr. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm. Res. 2002; 19: 1310-1316.
73. Lebedeva I, Benimetskaya L, Stein CA, Vilenchik M. Cellular delivery of antisense oligonucleotides. Eur. J. Pharm. Biopharm. 2000; 50: 101-119 [A Review].
74. Kim Y, Zimmerman SC. Applications of dendrimers in bio-organic chemistry. Curr. Opin. Chem. Biol. 1998; 2: 733-742 [A Review].
75. Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, Diop LA, Mulle R, Sudimack JJ, Lee RJ, Barth RF, Tjarks W. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug. Chem. 2003; 14: 158-167.
76. Barth RF, Soloway AH. Boron neutron-capture therapy of primary and metastatic brain-tumors. Mol. Chem. Neuropathol. 1994; 21: 139-154 [A Review].
77. Han S, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Mol. Therapy 2000; 2: 302-317 [A Review].
78. Supattapone S, Nguyen HOB, Cohen FE, Prusiner SB, Scott M. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 14529-14534.
79. Dykes GM, Smith DK. Supramolecular dendrimer chemistry: using dendritic crown ethers to reversibly generate functional assemblies. Tetrahedron 2003; 59: 3999-4009.
80. Edelman R, Wasserman SS, Kublin JG, Bodison SA, Nardin EH, Oliveira GA, Ansari S, Diggs CL, Kashala OL, Schmeckpeper BJ, Hamilton RG. Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. Vaccine 2002; 21: 269-280.
81. Ota S, Ono T, Morita A, Uenaka A, Harada M, Nakayama E. Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells. Cancer Res. 2002; 62: 1471-1476.
82. Kublin JG, Lowitt MH, Hamilton RG, Oliveira GA, Nardin EH, Nussenzweig RS, Schmeckpeper BJ, Diggs CL, Bodison SA, Edelman R. Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. Vaccine 2002; 20: 1853-1861.
83. Cruz LJ, Quintana D, Iglesias E, Garcia Y, Huerta V, Garay HE, Duarte C, Reyes O. Immunogenicity comparison of a multiantigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB 9 protein in mice. J. Pept. Sci. 2000; 6: 217-224.
84. Rivera Z, Granados G, Pinto M, Varon D, Carvajal C, Chaves F, Calvo J, Rodriguez R, Guzman F, Patarroyo ME. Double dimer peptide constructs are immunogenic and protective against Plasmodium falciparum in the experimental Aotus monkey model. J. Pept. Res. 2002; 59: 62-70.
85. Horváth A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. A lipophilic adjuvant carrier system for antigenic peptides. Lett. Pept. Sci. 2002; 8: 285-288.
86. Tam JP. Synthesis and applications of branched peptides in immunological methods and vaccines. In Peptides: Synthesis, Structures, and Applications, Gutte B (ed.). Academic Press: San Diego, 1995; 455-500 [A Review].
87. Dawson PE, Kent SBH. Synthesis of native proteins by chemical ligation. Annu. Rev. Biochem. 2000; 69: 923-960 [A Review].
88. Tam JP, Yu Q, Miao Z. Orthogonal ligation strategies for peptide and protein. Biopolymers (Peptide Sci.) 1999; 51: 311-332 [A Review].
89. Tam JP, Xu J, Eom KD. Methods and strategies of peptide ligation. Biopolymers (Peptide Sci.) 2001; 60: 194-205 [A Review].
90. Crespo L, Sanclimens G, Montaner B, Perez-Tomas R, Royo M, Pons M, Albericio F, Giralt E. Peptide dendrimers based on polyproline helices. J. Am. Chem. Soc. 2002; 124: 8876-8883.
91. Sanclimens G, Crespo L, Giralt E, Royo M, Albericio F. Solid-phase synthesis of second-generation polyproline dendrimers. Biopolymers (Peptide Sci.) 2004; 76: 283-297.
92. Baigude H, Katsuraya K, Okuyama K, Hatanaka K, Ikeda E, Shibata N, Uryu T. Synthesis of spherical and hemispherical sugar-containing polylornithine) dendrimers. J. Polym. Sci., Part A: Polym. Chem. 2004; 42: 1400-1414.
93. Baigude H, Katsuraya K, Okuyama K, Tokunaga S, Uryu T. Synthesis of sphere-type monodispersed oligosaccharide-polypeptide dendrimers. Macromolecules 2003; 36: 7100-7106.
94. Baigude H, Katsuraya K, Okuyama K, Yachi Y, Sato S, Uryu T. Synthesis of dicarboxylate oligosaccharide multilayer terminal functionality upon poly(lysine) dendrimer scaffolding. J. Polym. Sci. Part A: Polym. Chem. 2002; 40: 3622-3633.
95. Jensen KJ, Barany G. Carbopeptides: carbohydrates as potential templates for de novo design of protein models. J. Pept. Res. 2000; 56: 3-11.
96. Spetzler JC, Tam JP. Unprotected peptides as building blocks for branched peptides and peptide dendrimers. Int. J. Pept. Protein Res. 1995; 45: 78-85.
97. Shao J, Tam JP. Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages. J. Am. Chem. Soc. 1995; 117: 3893-3899.
98. Basak A, Boudreault A, Chen A, Chrétien M, Seidah NG, Lazure C. Application of the multiple antigenic peptides (MAP) strategy to the production of prohormone convertases antibodies: synthesis, characterization and use of 8-branched immunogenic peptides. J. Pept. Sci. 1995; 1: 385-395.
99. Vepřek P, Ježek J, Velek J, Tallima H, Montash M, El Ridi R. Peptides and multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase: preparation, immunogenicity and immunoprotective capacity in C57BL/6 mice. J. Pept. Sci. 2004; 10: 350-362.
100. Downard KM. Contributions of mass spectrometry to structural immunology. J. Mass Spectrom. 2000; 35: 493-503 [A Review].
101. Kinberger GA, Cai W, Goodman M. Collagen mimetic dendrimers. J. Am. Chem. Soc. Commun. 2002; 124: 15 162-15 163.
102. Zhang J, Jing B, Regen SL. Kinetic evidence for the existence and mechanism of formation of a barrel stave structure from pore-forming dendrimers. J. Am. Chem. Soc. 2003; 125: 13984-13987.
103. Scofield RH, Kurien BT, Gross JK, Reed NB, Taylor NK, Dominguez N, Mehta P, Guthridge JM, Bachmann M. Interaction of calcium and Ro60: increase of antigenicity. Mol. Immunol. 2004; 41: 809-816.
104. Gómara MJ, Ercilla G, Alsina MA, Haro I. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology. J. Immunol. Methods 2000; 246: 13-24.
105. Ortiz A, Cajal Y, Haro I, Reig F, Alsina MA. Fluorescence study on the interaction of a multiple antigenic peptide from hepatitis a virus with lipid vesicles. Biopolymers 2000; 53: 455-466.
106. Gómara MJ, Riedemann S, Vega I, Ibarra H, Ercilla G, Haro I. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis a virus infection. J. Immunol. Methods 2000; 234: 23-34.
107. Tu MP, Kou R, Wang ZS, Stoffolano JG, Yin ChM. Immunolocalization and possible effect of a moth allatotropin-like substance in a fly, Phormia regina (Diptera: Calliphoridae). J. Insect Physiol. 2001; 47: 233-244.
108. Gruber P, Suhr M, Frey A, Becker WM, Hofmann T. Development of an epitope-specific analytical tool for the major peanut allergen Ara h 2 using a high density multiple-antigenic peptide strategy. Mol. Nutr. Food Res. 2004; 48: 449-458.
109. Saravanan P, Kumar S, Kataria JM. Use of multiple antigenic peptides related to antigenic determinants of infectious bursal disease virus (IBDV) for detection of anti-IBDV-specific antibody in ELISA-quantitative comparison with native antigen for their use in serodiagnosis. J. Immunol. Methods 2004; 293: 61-70.
110. Giampaoli S, Facciabene A, Mennuni C. A protocol to guide development of a sensitive ELISA for canine erythropoietin. Veterinary Clin. Pathol. 2003; 32: 199-201.
111. Kim P, Pau ChP. Comparing tandem repeats and multiple antigenic peptides as the antigens to detect antibodies by enzyme immunoassay. J. Immunol. Methods 2001; 257: 51-54.
112. Ndongmo CB, Switzer WM, Pau CP, Zeh C, Schaefer A, Pieniazek D, Folks TM, Kalish ML. New multiple antigenic peptide-based enzyme immunoassay for detection of simian immunodeficiency virus infection in nonhuman primates and humans. J. Clin. Microbiol. 2004; 42: 5161-5169.
113. Oladepo DK, Klapper PE, Marsden HS. Peptide based enzyme-linked immunoassays for detection of anti-HSV-2 IgG in human sera. J. Virol. Methods 2000; 87: 63-70.
114. Mezo G, de Oliveira E, Krikorian D, Feijlbrief M, Jakab A, Tsikaris V, Sakarellos C, Welling-Wester S, Andreu D, Hudecz F. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Bioconjug. Chem. 2003; 14: 1260-1269.
115. Lam LL, Pau CP, Dollard SC, Pellett PE, Spira TJ. Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1. J. Clin. Microbiol. 2002; 40: 325-329.
116. Farkas I, Takahashi M, Fukuda A, Yamamoto N, Akatsu H, Baranyi L, Tateyama H, Yamamoto T, Okada N, Okada H. Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease. J. Immunol. 2003; 170: 5764-5771.
117. 35-55 peptide in C57BL6/J strain of mice. J. Autoimmun. 2003; 20: 51-61 [A Review].
118. Sharma A, Isenberg D, Diamond B. Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross-reactive antigens. Rheumatology 2003; 42: 453-460.
119. Vlachoyiannopoulos PG, Mavragani CP, Bourazopoulou E, Balitsari AV, Routsias JG. Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus. Thromb. Haemost. 2004; 92: 1303-1311.
120. Gerlí R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG, De Angelis V, Cesarotti M, Piccirilli M, Quartesan R, Moretti P, Cantoni C, Franceschini F, Cavazzana I, Origgi L, Vanoli M, Bozzolo E, Ferrario L, Padovani A, Gambini O, Vanzulli L, Croce D, Bombardieri S. Clinical and serological association of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology 2002; 41: 1357-1366.
121. Ghirardello A, Caponi L, Franceschini F, Zampieri S, Quinzanini M, Bendo R, Bombardieri S, Gambari PF, Doria A. Diagnostic tests for antiribosomal P protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J. Autoimmun. 2002; 19: 71-77.
122. Waldron EE, Muray P, Kolar Z, Young L, Brown C, Reynolds G, Baumforth K, Toomey S, Astley SJ, Perera SA, Nelson PN. Reactivity and isotype profiling of monoclonal antibodies using multiple antigenic peptides. Hybrid. Hybridomics 2002; 21: 393-398.
123. Marrakchi N, Mabrouk K, Regaya I, Sarray S, Fathallah M, Rochat H, El Ayeb M. Lebetin peptides: potent platelet aggregation inhibitors. Haemostasis 2001; 31: 207-210.
124. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergqvist R, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop. 2003; 88: 117-130.
125. El Ridi R, Mahrous A, Afifi A, Montash M, Velek J, Ježek J. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to schistosomiasis. Scand. J. Immunol. 2001; 54: 477-485.
126. Tallima H, Montash M, Vepřek P, Velek J, Ježek J, El Ridi R. Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Vaccine 2003; 21: 3290-3300.
127. El Ridi R, Montash M, Tallima H. Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Scand. J. Immunol. 2004; 60: 392-402.
128. Huang HQ, Li SC, Qin ZH, Cao SL, Yao Y, Liu YS, Li HY, Cai MS, Li ZJ, Shi YE. Synthesis and bioactivides of two multiple antigen peptides as potential vaccine against schistosoma. Bioorg. Med. Chem. Lett. 2005; 15: 2415-2419.
129. Joshi MB, Gam AA, Boykins RA, Kumar S, Sacci J, Hoffman SL, Nakhasi HL, Kenney RT. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates. Infect. Immun. 2001; 69: 4884-4890.
130. Vasconcelos NM, Siddique AB, Ahlborg N, Berzins K. Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes. Vaccine 2004; 23: 343-352.
131. Nardin EH, Calvo-Calle JM, Oliveira GA, Nussenzweig RS, Schneider M, Tiercy JM, Loutan L, Hochstrasser D, Rose K. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. J. Immunol. 2001; 166: 481-489.
132. Avila SML, Goldberg AC, Arruk VG, Marin ML, Guilherme L, Kalil J, Ferreira AW. Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malaria. Parasite Immunol. 2001: 23: 103-108.
133. Nardin EH, Oliveira GA, Calvo-Calle JM, Castro ZR, Nussenzweig RS, Schmeckpeper B, Hall BF, Diggs C, Bodison S, Edelman R. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccines of defined HLA genotypes. J. Infect. Dis. 2000; 182: 1486-1496.
134. Chaves F, Calvo JC, Carvajal C, Rivera Z, Ramirez L, Pinto M, Trujillo M, Guzman F, Patarroyo ME. Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages. J. Pept. Res. 2001; 58: 307-316.
135. Moreno R, Jiang L, Moehle K, Zurbriggen R, Gluck R, Robinson JA, Pluschke G. Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design. Chembiochem 2001; 2: 838-843.
136. Dat MHQ, Behr Ch, Jouin H, Baleux F, Mercereau-Puijalon O, Dubois P. Mimicking a conformational B cell epitope of the heat shock protein PfHsp70-1 antigen of Plasmodium falciparum using a multiple antigenic peptide. Parasite Immunol. 2000; 22: 535-543.
137. + cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture. Infect. Immun. 2000; 68: 3403-3411.
138. Deng X, Meyers SA, Tollner TL, Yudin AI, Primakoff PD, He DN, Overstreet JW. Immunological response of female macaques to the PH-20 sperm protein following injection of recombinant proteins or synthesized peptides. J. Reprod. Immunol. 2002; 54: 93-115.
139. Takada I, Noguchi Y, Kenjo A, Wada H, Uenaka A, Fujita T, Inoue H, Nakayama E. Analysis of CD8 T-cell response by IFN gamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/cxC57BL/6) F-1 mice. Cancer Sci. 2004; 95: 254-259.
140. Ciesielski MJ, Kazim AL, Barth RF, Fenstermaker RA. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model. Cancer Immunol. Immunother. 2005; 54: 107-119.
141. Uenaka A, Nakayama E. Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL). Cancer Sci. 2003; 94: 931-936.
142. Montigiani S, Muller R, Kontermann RE. Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2F. Oncogene 2003; 22: 4943-4952.
143. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Shamloo S, Blaszcyk-Thurin M, Kieber-Emmons T. Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses. Int. Immunol. 2001; 13: 1361-1371.
144. Iglesias E, Aguilar JC, Cruz LJ, Reyes O. Broader cross-reactivity after conjugation of V3 based multiple antigen peptides to HbsAg. Mol. Immunol. 2005; 42: 99-104.
145. Cruz W, Iglesias E, Aguilar JC, Cabrales A, Reyes O, Andreu D. Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1. Bioconjug. Chem. 2004; 15: 1110-1117.
146. Cruz LJ, Iglesias E, Aguilar JC, Gonzales LJ, Reyes O, Albericio F, Andreu D. A comparative study of different presentation strategies for an HIV peptide immunogen. Bioconjug. Chem. 2004; 15: 112-120.
147. Misumi S, Endo M, Mukai R, Tachibana K, Umeda M, Honda T, Takamune N, Shoji S. A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression. J. Biol. Chem. 2003; 278: 32 335-32 343.
148. 178) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine. J. Virol. 2001; 75: 11614-11620.
149. Misumi S, Takamune N, Ido Y, Hayashi S, Endo M, Mukai R, Tachibana K, Umeda M, Shoji S. Evidence as a HIV-1 self-defence vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4. Biochem. Biophys. Res. Commun. 2001; 285: 1309-1316.
150. 3 interferes with CXCR4. FEMS Microbiol. Lett. 2000; 183: 235-240.
151. Barbouche R, Decroly E, Kieny MP, Ferrouillet E. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the Env precursor interferes with membrane fusion at a post-CD4 binding step. Virology 2000; 273: 169-177.
152. Barbouche R, Feyfant E, Belhaj B, Fenouillet E. Pharmacophore determination of a gp120 C terminal-derived anti-HIV peptide construct interfering with membrane fusion suggesting that processing of the gp120 C terminus is a prelude to fusion. AIDS Res. Hum. Retroviruses 2002; 18: 201-206.
153. Wang LX, Ni J, Singh S. Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling: synthesis of multivalent HIV-1 gp41 peptides. Bioorg. Med. Chem. 2003; 11: 159-166.
154. Vogel TU, Beer BE, Megede J, Ihlenfeldt HG, Jung G, Holzammer S, Watkins DI, Altman JD, Kurth R, Norley S. Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge. J. Gen. Virol. 2002; 83: 81-95.
155. Ridgely SL, McGuire TC. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T-lymphocytes from equine infectious anemia virus-infected horses. Vaccine 2002; 20: 1809-1819.
156. Olszewska W, Partidos ChD, Steward MW. Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants. Infect. Immun. 2000; 68: 4923-4929.
157. Olszewska W, Obeid OE, Steward MW. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Virology 2000; 272: 98-105.
158. Mozdzanowska K, Feng J, Eid M, Kragol G, Cudic M, Otvos L Jr, Gerhard W. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 2003; 21: 2616-2626.
159. Haro I, Peres S, Garcia M, Chan WC, Ercilla G. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. FEBS Lett. 2003; 540: 133-140.
160. 2 region of surface antigen of viral hepatitis B screened by phage display. Cell Res. 2001; 11: 203-208.
161. Bainbridge J, Jones N, Walker B. Multiple antigenic peptides facilitate generation of anti-prion antibodies. Clin. Exp. Immunol. 2004; 137: 298-304.
162. Arbel M, Lavie V, Solomon B. Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization. J. Neuroimmunol. 2003; 144: 38-45.
163. Taborda CP, Nakaie CR, Cilli EM, Rodrigues EG, Silva LS, Franco MF, Travassos LR. Synthesis and immunological activity of a branched peptide carrying the T-cell epitope of gp43, the major exocellular antigen of Paracoccidioides brasilliensis. Scand. J. Immunol. 2004; 59: 58-65.
164. Olsen AW, Hansen PR, Holm A, Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur. J. Immunol. 2000; 30: 1724-1732.
165. Cunto-Amesty G, Luo P, Monzavi-Karbassi B, Lees A, Alexander J, Del Guericio MF, Nahm MH, Arland C, Stanley J, Kieber-Emmons T. Peptide mimotopes as prototypic templates of broad spectrum surrogates of carbohydrate antigens. Cell. Mol. Biol. 2003; 49: 245-254.
166. Smith DJ, King WF, Barnes LA, Peacock Z, Taubman MA. Immunogenicity and protective immunity induced by synthetic peptides associated with putative immunodominant regions of Streptococcus mutans glucan-binding protein B. Infect. Immun. 2003; 71: 1179-1184.
167. Smith DJ, King WF, Rivero J, Taubman MA. Immunological and protective effects of diepitopic subunit dental caries vaccines. Infect. Immun. 2005; 73: 2797-2804.
168. Cavenaugh JS, Wang HK, Hansen C, Smith RS, Herron JN. How well can a T-cell epitope replace its parent carrier protein? A dose-response study. Pharm. Res. 2003; 20: 591-596.
169. Davis A, Wegner DH. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull. W. H. O. 1979; 57: 767-771.
170. Caro-Aguilar I, Rodriguez A, Calvo-Calle JM, Guzman F, De la Vega P, Patarroyo ME, Galinski MR, Moreno A. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. Infect. Immun. 2002; 70: 3479-3492.
171. Tsuji M, Zavala F. Peptide-based subunit vaccines against preerythrocytic stages of malaria parasites. Mol. Immunol. 2001; 38: 433-442 [A Review].
172. Olszewska W, Steward MW. Nasal delivery of epitope based vaccines. Adv. Drug Delivery Rev. 2001; 51: 161-171 [A Review].
173. Cavallaro V, Thompson P, Hearn M. Solid-phase synthesis of a dendritic peptide related to a retinoblastoma protein fragment utilizing a combined Boc-and Fmoc-chemistry approach. J. Pept. Sci. 2001; 7: 262-269.